- 404, G41 -

Delivering on the promiseof treatments for rare disease Transforming drug development for rare disease Odylia delivers on the promise of treatments for the vastly underserved rare disease patient community. By pivoting to a nonprofit drug development model and away from the economic barriers and unaligned incentives of the traditional model Odylia increases drug development while accelerating timelines and reducing costs. Odylias Portfolio Services Odylia Therapeutics is a nonprofit biotech developing therapies for rare diseases that have no available treatment. By integrating scientific knowledge operational excellence and technological innovation Odylia offers hope and improved health impacting current and future generations.